Incyte Corporation (Nasdaq:INCY) announced today that it has submitted a New Drug Application (NDA) for its lead investigational compound, ruxolitinib (INCB18424), to the US Food and Drug Administration (FDA)...
Roche, Bristol Melonoma Drug Cocktail; What's In It?
6/07/2011
There are several ways to combat deadly melanoma. One way is to attack the cancer by bolstering the body's immune system to fight the disease. Another way is to block a genetic mutation known as BRAF, which may help the disease grow. This week it was announced that two giants, Bristol Meyers Squibb and Roche will combine forces to find a best practice solution...
Bankruptcy Rates Among Cancer Patients Increase Along With Survival Time
6/07/2011
An analysis linking federal bankruptcy court records to cancer registry data from nearly 232,000 adult cancer cases in western Washington during a 14-year period has found a hidden cost to survival: Insolvency rates increase along with the length of survival...
Overcoming Cognitive Effects Of Chemotherapy With The Help Of Tai Chi
6/07/2011
According to the American Cancer Society, more than 11.4 million Americans are currently living with cancer. While cancer treatments are plentiful, many have negative side effects. Previous studies have indicated that a significant number of patients who receive chemotherapy also experience cognitive declines, including decreases in verbal fluency and memory...
Role For Cell Scaffold In Tumor Formation Revealed
6/07/2011
A group of scientists at the Instituto Gulbenkian de Ciencia, in Portugal, have uncovered a surprising link between the cell's skeleton and organ size. The team, led by Florence Janody, show in the journal Development, that one of the proteins that regulates the skeleton of the cell also acts to block activation of genes that promote cell survival and proliferation...
Link Between Blood Clotting And Bowel Cancer Risk
6/07/2011
Back in the mid 19th century, a French doctor, Armand Trousseau, discovered a connection between cancer and thrombosis - the formation of often dangerous blood clots that can lead to venous occlusion. Today it is known that cancer and its treatment change blood flow properties and thus promote the formation of clots...
Rectal Cancer, Palliative Care, Benchmarking Studies Presented At ASCO By City Of Hope Researchers
6/07/2011
City of Hope researchers participated in more than 50 studies on improvements to cancer treatment, patient care and clinical trials presented at the 2011 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, running from June 3 through 7...
CDG Therapeutics, Inc. today announced results from a clinical Phase I human trial of a novel platform technology utilizing p28, a synthetic, Azurin-derived peptide. Fifteen refractory (Stage IV) solid tumor patients with p53+ lesions were enrolled in an escalating, five-dose level (.83, 1.66, 2.5, 3.33, and 4...
Veterans Health Administration Similar Or Better Than Private Sector For Cancer Patients Ages 65+
6/07/2011
A new study finds that the cancer care provided by the Veterans Health Administration (VHA) for men 65 years and older is at least as good as, and by some measures better than, Medicare-funded fee-for-service care obtained through the private sector...
Removal Of A Tiny RNA Molecule Can Inhibit Cancer Growth
6/07/2011
Research from the University of Louisville published in the Proceedings of the National Academy of Sciences indicates the removal of a tiny RNA molecule in mice suppresses carcinogenic tumor formation. The study appears in the journal's Early Edition online. Yong Li, Ph.D...